SK281934B6 - Deriváty 5-(hydroxymetyl)oxazolidin-2-ónu, spôsob ich prípravy a farmaceutická kompozícia - Google Patents

Deriváty 5-(hydroxymetyl)oxazolidin-2-ónu, spôsob ich prípravy a farmaceutická kompozícia Download PDF

Info

Publication number
SK281934B6
SK281934B6 SK1614-97A SK161497A SK281934B6 SK 281934 B6 SK281934 B6 SK 281934B6 SK 161497 A SK161497 A SK 161497A SK 281934 B6 SK281934 B6 SK 281934B6
Authority
SK
Slovakia
Prior art keywords
formula
group
compound
atom
hydrogen atom
Prior art date
Application number
SK1614-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK161497A3 (en
Inventor
Samir Jegham
Fr�D�Ric Puech
Philippe Burnier
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK281934(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9506563A external-priority patent/FR2734820B1/fr
Priority claimed from FR9506564A external-priority patent/FR2734821B1/fr
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SK161497A3 publication Critical patent/SK161497A3/sk
Publication of SK281934B6 publication Critical patent/SK281934B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1614-97A 1995-06-02 1996-05-28 Deriváty 5-(hydroxymetyl)oxazolidin-2-ónu, spôsob ich prípravy a farmaceutická kompozícia SK281934B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9506563A FR2734820B1 (fr) 1995-06-02 1995-06-02 Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR9506564A FR2734821B1 (fr) 1995-06-02 1995-06-02 Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
PCT/FR1996/000792 WO1996038444A1 (fr) 1995-06-02 1996-05-28 Derives d'oxazolidinone, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
SK161497A3 SK161497A3 (en) 1998-05-06
SK281934B6 true SK281934B6 (sk) 2001-09-11

Family

ID=26232004

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1614-97A SK281934B6 (sk) 1995-06-02 1996-05-28 Deriváty 5-(hydroxymetyl)oxazolidin-2-ónu, spôsob ich prípravy a farmaceutická kompozícia

Country Status (27)

Country Link
US (1) US5843975A (ja)
EP (1) EP0835254B1 (ja)
JP (1) JP3856829B2 (ja)
KR (1) KR100457502B1 (ja)
CN (1) CN1075072C (ja)
AR (1) AR006301A1 (ja)
AT (1) ATE184005T1 (ja)
AU (1) AU699367B2 (ja)
BR (1) BR9608896A (ja)
CA (1) CA2223011C (ja)
CO (1) CO4700462A1 (ja)
CZ (1) CZ378497A3 (ja)
DE (1) DE69604071T2 (ja)
DK (1) DK0835254T3 (ja)
ES (1) ES2138346T3 (ja)
GR (1) GR3031710T3 (ja)
HK (1) HK1014938A1 (ja)
HU (1) HU224879B1 (ja)
MX (1) MX9709410A (ja)
NO (1) NO309091B1 (ja)
NZ (1) NZ310487A (ja)
PL (1) PL183919B1 (ja)
RU (1) RU2164226C2 (ja)
SK (1) SK281934B6 (ja)
TW (1) TW360654B (ja)
WO (1) WO1996038444A1 (ja)
ZA (1) ZA964563B (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
HUP0401858A3 (en) * 2001-01-31 2009-06-29 Lundbeck & Co As H Gal3 receptor antagonist pyrimidine and indolone-derivatives and their use for preparation of pharmaceutical compositions suitable for the treatment of depression and/or anxiety
IL160744A0 (en) * 2001-09-26 2004-08-31 Pharmacia Italia Spa Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
EP2032565A2 (en) * 2006-02-01 2009-03-11 Pfizer Products Inc. Benzisoxazole oxazolidinones as antibacterial agents
EP2141154A4 (en) * 2007-03-30 2011-06-01 Inst Med Molecular Design Inc OXAZOLIDINONE DERIVATIVE HAVING INHIBITORY ACTIVITY ON 11-HYDROXYSTEOID DEHYDROGENASE TYPE I
EP2123159A1 (de) * 2008-05-21 2009-11-25 Bayer CropScience AG (1,2-Benzisothiazol-3-yl)(thio)carbamate und (1,2-Benzisothiazol-3-yl)(thio)oxamate und deren Oxidationsformen als Pestizide
JP2013514385A (ja) * 2009-12-18 2013-04-25 ヤンセン ファーマシューティカ エヌ．ベー． エストロゲン関連受容体αモジュレーターとしての置換アミノチアゾロンインダゾール
RU2012139459A (ru) * 2010-02-17 2014-03-27 Янссен Фармацевтика Нв Аминотиазолоны для использования в качестве модуляторов родственных эстрогену рецепторов альфа
WO2016097355A1 (en) * 2014-12-19 2016-06-23 Ge Healthcare Limited Labelled oxazolidinone derivatives
DE102015012050A1 (de) * 2015-09-15 2017-03-16 Merck Patent Gmbh Verbindungen als ASIC-Inhibitoren und deren Verwendungen
RU2637643C1 (ru) * 2016-09-05 2017-12-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" (НИИФКИ) Иммунодепрессант

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235063A (en) * 1989-10-17 1993-08-10 Delalande S.A. Process of preparing by condensation certain
US5196543A (en) * 1989-10-17 1993-03-23 Delalande S.A. 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
FR2653017B1 (fr) * 1989-10-17 1995-05-05 Delalande Sa Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5182296A (en) * 1989-10-26 1993-01-26 Tanabe Seiyaky Co., Ltd. Naphthyloxazolidone derivatives
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
AU1209092A (en) * 1991-02-20 1992-09-15 Yusaku Koda Articulator

Also Published As

Publication number Publication date
PL183919B1 (pl) 2002-08-30
GR3031710T3 (en) 2000-02-29
TW360654B (en) 1999-06-11
ZA964563B (en) 1996-12-12
JPH11507330A (ja) 1999-06-29
ATE184005T1 (de) 1999-09-15
RU2164226C2 (ru) 2001-03-20
HUP9901349A2 (hu) 1999-08-30
CN1075072C (zh) 2001-11-21
NO309091B1 (no) 2000-12-11
CA2223011A1 (en) 1996-12-05
EP0835254B1 (fr) 1999-09-01
HUP9901349A3 (en) 2000-02-28
WO1996038444A1 (fr) 1996-12-05
JP3856829B2 (ja) 2006-12-13
PL323673A1 (en) 1998-04-14
KR19990022187A (ko) 1999-03-25
CA2223011C (en) 2007-01-09
ES2138346T3 (es) 2000-01-01
SK161497A3 (en) 1998-05-06
US5843975A (en) 1998-12-01
CO4700462A1 (es) 1998-12-29
DE69604071T2 (de) 2000-04-06
BR9608896A (pt) 1999-06-29
HK1014938A1 (en) 1999-10-08
DK0835254T3 (da) 2000-03-27
DE69604071D1 (de) 1999-10-07
EP0835254A1 (fr) 1998-04-15
MX9709410A (es) 1998-07-31
CZ378497A3 (cs) 1998-04-15
NO975530L (no) 1998-02-02
HU224879B1 (en) 2006-03-28
AU6128896A (en) 1996-12-18
KR100457502B1 (ko) 2005-09-05
NZ310487A (en) 1999-05-28
AU699367B2 (en) 1998-12-03
AR006301A1 (es) 1999-08-25
NO975530D0 (no) 1997-12-01
CN1191534A (zh) 1998-08-26

Similar Documents

Publication Publication Date Title
CN103429590B (zh) 作为bace1和/或bace2抑制剂的1，4硫氮杂*/砜
CA2770932C (en) Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines
IL177939A (en) Aryl piperidines or piperazines converted into pentagonal heterocyclic rings and a pharmaceutical composition containing them
FR2581993A1 (fr) Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
FR2967674A1 (fr) Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine
JPS6043064B2 (ja) 新規イソオキサゾ−ル誘導体
CA2176668C (fr) Nouveaux composes spiro heterocycliques, leur procede de preparation et les compositions pharmaceutiques les contenant
EP0433149B1 (fr) Antagonistes de la sérotonine, leur préparation et les médicaments les contenant
EP0350403A1 (fr) Dérivés de (aza)naphtalènesultame, leurs procédés de préparation et les médicaments les contenant
JP2009256363A (ja) ５−ｈｔ２ａ拮抗剤としてのオキサゾリジン類
SK281934B6 (sk) Deriváty 5-(hydroxymetyl)oxazolidin-2-ónu, spôsob ich prípravy a farmaceutická kompozícia
CA1296002C (en) Substituted thiazoles and oxazoles, medicaments containing these compounds, and processes for their preparation
JP5255568B2 (ja) 迅速に解離するドーパミン２受容体アンタゴニストとしてのピペリジニルアミノ−ピリダジンおよびそれらの使用
EP0114850B1 (fr) Nouveaux derives substitues du 2,5-diamino 1,4-diazole, leurs procedes de preparation et les compositions pharmaceutiques en renfermant
EP0841330B1 (fr) Nouveaux dérivés aminométhyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CA3148365A1 (en) Alpha-d-galactopyranoside derivatives
EP1790646A1 (fr) Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3.
HU203548B (en) Process for producing benzoxazine derivatives and pharmaceutical compositions containing them
JP2000219678A (ja) ベンゼン誘導体又はピリジン誘導体
FR2467205A1 (fr) Derives d'acide benzo(ij)quinolizine carboxylique-2, utiles notamment comme medicaments antimicrobiens, procede de leur preparation et compositions therapeutiques et formes pharmaceutiques les contenant
WO1997013768A1 (fr) Composes derives d'oxazolidin-2-one, leur procede de preparation et leur application en therapeutique
US4985427A (en) Triazine derivatives
EP1773823B1 (fr) Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
FR2605008A1 (fr) Derives d'imidazo (4,5-b)pyridinone-2, leur preparation et leur application en therapeutique
BE885264A (fr) Nouveaux derives de carbostyrile, leur procede de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20160528